Conference Chair
Michael Graner
Professor, University of Colorado Anschutz School of Medicine |
 Keynote Speakers
Behzad Mahdavi
Vice President of Strategic Innovation & Alliances, Lonza | 
My Mahoney
Professor and Vice Chair, Thomas Jefferson University | 
John Nolan
CEO, Cellarcus Biosciences, Inc. | 
Dana Larocca
VP Discovery Research, AgeX Therapeutics | 
Mei He
Assistant Professor, University of Kansas and Chief Science Officer of Clara Biotech | 
Dolores Di Vizio
Professor, Cedars Sinai Medical Center |
|
Lucia Languino
Professor of Cancer Biology, Thomas Jefferson University | 
Susanne Gabrielsson
Professor, Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet | 
Jan Lötvall
Professor, University of Gothenburg; Founding President of ISEV; Editor-in-Chief, Journal of Extracellular Vesicles | 
Randolph Corteling
Head of Research, ReNeuron Ltd. | 
Steven Stice
Co-Founder and Chief Scientific Officer, Aruna Bio; DW Brook Distinguished Professor and Director of the Regenerative Bioscience Center, Georgia Research Alliance Eminent Scholar, University of Georgia | 
Paul Robbins
Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School | 
Lorraine O’Driscoll
Professor in Pharmacology, Trinity College Dublin | 
Daniel Chiu
A. Bruce Montgomery Professor of Chemistry, University of Washington | 
Dominique PV de Kleijn
Professor Experimental Vascular Surgery, Professor Netherlands Heart Institute, University Medical Center Utrecht, The Netherlands | 
Raghu Kalluri
Professor and Chairman, Department of Cancer Biology, University of Texas MD Anderson Cancer Center | 
Min Yu
Assistant Professor, University of Southern California | 
Chulhee Choi
Professor and Chair, BioMedical Imaging Center, Korea Advanced Institute of Science and Technology (KAIST), President, ILIAS Biologics Incorporated | 
Jennifer Jones
NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute |
OverviewSelectBIO EV-based Diagnostics, Delivery & Therapeutics 2020 Conference brings together the most up-to-date technologies and advances in this
expanding and evolving field. Our coverage in this conference focuses
on the various research efforts and applications of Exosomes/Extracellular Vesicles (EVs) in the following major topic areas: - Extracellular Vesicles (EVs): Exosomes and Microvesicles -- Research Activities
- Exosome/EV Engineering -- Engineered Exosomes for Delivery
- Drug Delivery via Engineered Vesicles
- Exosomes/EV-based Therapeutics Development
This
conference features an international faculty of speakers from academia
as well as industry addressing the following topic areas: - Technologies for Isolation and Characterization: Single Vesicle Analysis Approaches
- Role in Cancer and Various Disease Classes
- Biomarker Potential for Diagnostics Development
- Therapeutics Potential and Technology Advances in the EV Field as well as Drug Delivery and Therapeutics Development
The ability to engineer EVs and the ability of EVs to target specific
sites offers the ability to tailor therapeutics with "exquisite targeting
ability" and opens up a whole new class of therapeutics which are
classified as biologicals and which do not have the side effects and
toxicity associated with small molecule-based therapies. This conference explores this topic and takes a deep dive into the technology
platforms, diseases targeted and clinical results-to-date.
|
Slide Deck Downloads: Exosomes Technology Analysis Slide Deck 2018
Liquid Biopsy Slide Deck 2018
Registered
delegates receive access to the co-located concurrent conference
tracks, the co-located exhibit hall featuring companies from around the
world providing tools/technologies, products and services. Conference Presentations and Content Organization - Circulating Biomarkers 2020
- EV-based Diagnostics, Delivery and Therapeutics 2020
- EVs and Stem Cells Summit 2020 -- Speakers from this Track are in the Two Co-Located Tracks
|
Information and Local Registration Facilities for this Conference are Also Available In:
 Japanese
|
 Korean
|
 Chinese (Simplified)
|
 Chinese (Traditional)
Session Sponsors
Agenda Topics- Engineered Exosomes and Extracellular Vesicles (EVs) for Delivery
- Engineering EVs as Biologic Drugs
- Ex Vivo Production of Large Quantities of EVs: Challenges and Opportunities
- Exosomes-based Diagnostics/Liquid Biopsy Development
- Diagnostics Markers Carried by Exosomes
- Liquid Biopsy Enabled by Analyzing Exosomes
- Exosomes/EVs-based Drug Delivery
- Flow Cytometry and Single EV Analysis: A New Paradigm in Exosomes/EV Research
- Stem Cell-based EVs for Regenerative Medicine
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865
|
Confirmed Speakers to dateJohnathon Anderson, Assistant Professor, University of California-Davis
Mei He, Assistant Professor, University of Kansas and Chief Science Officer, Clara Biotech
Sazid Hussain, Research Assistant Professor, Sanford Burnham Prebys Medical Discovery Institute
Alina Lelic, Marketing Manager, North America, Beckman Coulter
Juliane Nguyen, Associate Professor, University of North Carolina at Chapel Hill
John Nolan, CEO, Cellarcus Biosciences, Inc.
Robert Raffai, Professor, University of California-San Francisco
Kendall Van Keuren-Jensen, Professor and Deputy Director, Translational Genomics Research Institute
Aijun Wang, Chancellor's Fellow Professor, University of California-Davis
Jim West, CEO, Clara Biotech
William Whitford, Strategic Solutions Leader, GE Healthcare Life Sciences
|
|
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|
|
Add to Calendar ▼2020-02-17 00:00:002020-02-18 00:00:00Europe/LondonEV-based Diagnostics, Delivery and TherapeuticsEV-based Diagnostics, Delivery and Therapeutics in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com
